• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Towards ending viral hepatitis as a public health threat: translating new momentum into concrete results in South-East Asia.

作者信息

Singh Poonam Khetrapal

机构信息

World Health Organization, Regional Office for South-East Asia, World Health House, Indraprastha Estate, Mahatma Gandhi Marg, New Delhi, 110 002 India.

出版信息

Gut Pathog. 2018 Mar 5;10:9. doi: 10.1186/s13099-018-0237-x. eCollection 2018.

DOI:10.1186/s13099-018-0237-x
PMID:29515657
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5836424/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d2b/5836424/5e303ff69070/13099_2018_237_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d2b/5836424/c480f732e3e0/13099_2018_237_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d2b/5836424/0cb158db5ff7/13099_2018_237_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d2b/5836424/5e303ff69070/13099_2018_237_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d2b/5836424/c480f732e3e0/13099_2018_237_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d2b/5836424/0cb158db5ff7/13099_2018_237_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d2b/5836424/5e303ff69070/13099_2018_237_Fig3_HTML.jpg

相似文献

1
Towards ending viral hepatitis as a public health threat: translating new momentum into concrete results in South-East Asia.终结病毒性肝炎这一公共卫生威胁：将新动力转化为东南亚地区的具体成果。
Gut Pathog. 2018 Mar 5;10:9. doi: 10.1186/s13099-018-0237-x. eCollection 2018.
2
Mitigating the impact of the COVID-19 pandemic on progress towards ending tuberculosis in the WHO South-East Asia Region.减轻新冠疫情对世界卫生组织东南亚区域终结结核病进展的影响。
WHO South East Asia J Public Health. 2020 Sep;9(2):95-99. doi: 10.4103/2224-3151.294300.
3
Micronutrient deficiencies and their public health implications for South-East Asia.东南亚微量营养素缺乏及其对公共卫生的影响。
Curr Opin Clin Nutr Metab Care. 2019 Nov;22(6):479-482. doi: 10.1097/MCO.0000000000000603.
4
Similarities and Differences in Autoimmune Hepatitis Epidemiology between East and West: Autoimmune Hepatitis in East Asia, Southeast Asia, and South Asia.东西方自身免疫性肝炎流行病学的异同：东亚、东南亚和南亚的自身免疫性肝炎
Inflamm Intest Dis. 2017 Apr;1(4):150-158. doi: 10.1159/000454879. Epub 2017 Feb 3.
5
Retrospective use of next-generation sequencing reveals the presence of Enteroviruses in acute influenza-like illness respiratory samples collected in South/South-East Asia during 2010-2013.对下一代测序技术的回顾性应用揭示了2010年至2013年期间在南亚/东南亚采集的急性流感样疾病呼吸道样本中存在肠道病毒。
J Clin Virol. 2017 Sep;94:91-99. doi: 10.1016/j.jcv.2017.07.004. Epub 2017 Jul 14.
6
Ending TB in South-East Asia: flagship priority and response transformation.东南亚终结结核病：旗舰重点与应对转型
Lancet Reg Health Southeast Asia. 2023 Oct 29;18:100301. doi: 10.1016/j.lansea.2023.100301. eCollection 2023 Nov.
7
Essential programme on immunization in WHO South-East Asia: A five-decade journey of saving millions of lives & ending diseases.世界卫生组织东南亚地区免疫基本规划：拯救数百万人生命并终结疾病的五十年历程
Indian J Med Res. 2024;160(3&4):267-278. doi: 10.25259/IJMR_1527_2024.
8
Changing trends in viral hepatitis mortality in East and Southeast Asia between 1987 and 2015 and its prediction until 2030.1987年至2015年期间东亚和东南亚病毒性肝炎死亡率的变化趋势及其至2030年的预测。
Liver Int. 2020 Feb;40(2):298-307. doi: 10.1111/liv.14289. Epub 2019 Dec 4.
9
Viral hepatitis in East Asia.东亚的病毒性肝炎
J Formos Med Assoc. 1996 Jan;95(1):6-12.
10
A(H5N1) Virus Evolution in South East Asia.东南亚的 H5N1 病毒演变。
Viruses. 2009 Dec;1(3):335-61. doi: 10.3390/v1030335. Epub 2009 Oct 6.

引用本文的文献

1
Hepatitis B immunisation and immune status of nurses in a regional hospital in central South Africa.南非中南部一家地区医院护士的乙型肝炎免疫接种和免疫状况。
S Afr Fam Pract (2004). 2024 Jun 26;66(1):e1-e9. doi: 10.4102/safp.v66i1.5871.
2
Seroprevalence of hepatitis B and C virus among highly active antiretroviral therapy experienced children in Gondar, Ethiopia.埃塞俄比亚贡德尔接受高效抗逆转录病毒治疗的儿童中乙型和丙型肝炎病毒的血清流行率。
Trop Med Health. 2022 Dec 21;50(1):97. doi: 10.1186/s41182-022-00489-2.
3
Prevalence of Hepatitis B, Hepatitis C, and HIV in Multiply Transfused Sickle Cell Disease Patients from Oman.

本文引用的文献

1
Status and progress of hepatitis B control through vaccination in the South-East Asia Region, 1992-2015.1992-2015 年东南亚地区通过疫苗接种控制乙型肝炎的现状和进展。
Vaccine. 2018 Jan 2;36(1):6-14. doi: 10.1016/j.vaccine.2017.11.027. Epub 2017 Nov 22.
2
Newer direct-acting antivirals for hepatitis C virus infection: Perspectives for India.新型直接作用抗病毒药物治疗丙型肝炎病毒感染：印度视角。
Indian J Med Res. 2017 Jul;146(1):23-33. doi: 10.4103/ijmr.IJMR_679_15.
阿曼多次输血的镰状细胞病患者中乙型肝炎、丙型肝炎和艾滋病毒的流行情况。
Mediterr J Hematol Infect Dis. 2019 Nov 1;11(1):e2019058. doi: 10.4084/MJHID.2019.058. eCollection 2019.
4
Alteration in gut microbiota associated with hepatitis B and non-hepatitis virus related hepatocellular carcinoma.与乙型肝炎和非肝炎病毒相关肝细胞癌相关的肠道微生物群改变。
Gut Pathog. 2019 Jan 18;11:1. doi: 10.1186/s13099-018-0281-6. eCollection 2019.
5
Update on global epidemiology of viral hepatitis and preventive strategies.全球病毒性肝炎流行病学及预防策略的最新情况
World J Clin Cases. 2018 Nov 6;6(13):589-599. doi: 10.12998/wjcc.v6.i13.589.